As per MRFR analysis, the US Absorbable Heart Stent Market Size was estimated at 23.81 (USD Million) in 2023. The US Absorbable Heart Stent Market Industry is expected to grow from 27.5(USD Million) in 2024 to 169 (USD Million) by 2035. The US Absorbable Heart Stent Market CAGR (growth rate) is expected to be around 17.947% during the forecast period (2025 - 2035).
The US Absorbable Heart Stent Market has been trending towards increased adoption and innovation in recent years. One major driver is the rising prevalence of coronary artery disease, which has motivated healthcare providers to explore advanced treatment options such as absorbable stents. These stents offer the benefit of temporary support to the arterial wall, allowing for natural vessel healing while minimizing long-term complications.
As awareness regarding the advantages of absorbable stents grows, more patients and physicians are opting for these devices over traditional metallic stents. In terms of opportunities, there is a considerable potential for research and development in the US. The ongoing advancements in biocompatible materials and drug-eluting technologies present avenues for companies to improve stent performance and patient outcomes.
Additionally, with healthcare policies in the US promoting minimally invasive procedures and cost-effective treatments, companies developing absorbable stents may find favorable conditions for market entry and expansion. Recently, there has been a noticeable trend towards the integration of digital health solutions that accompany the use of absorbable stents.
Technologies such as remote monitoring and data analytics not only enhance patient management but can also influence the design of future stents. Regulatory bodies in the US are also working towards streamlined approval processes for innovative medical devices, further fostering a conducive environment for the growth of the absorbable heart stent market.
Collectively, these trends indicate a dynamic shift in cardiac care, emphasizing patient-centered approaches and technological advancements to improve treatment efficacy and safety.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Cardiovascular diseases continue to be one of the leading causes of death in the United States, accounting for approximately 697,000 deaths in 2020 alone, according to the Centers for Disease Control and Prevention (CDC). This growing prevalence of heart-related ailments significantly drives the US Absorbable Heart Stent Market Industry, as absorbable stents are increasingly preferred due to their temporary presence in the blood vessel.
As the American Heart Association (AHA) projects a significant rise in cardiovascular incidences, with an increase of about 10% over the next decade, the adoption of absorbable stents is expected to grow accordingly. The heightened focus on advanced treatment options, fueled by the aging population and lifestyle changes, encourages healthcare providers to invest in innovative solutions like absorbable stents.
Additionally, organizations like the Food and Drug Administration (FDA) have been progressively approving more absorbable stent technologies, thereby facilitating market expansion.
Recent advancements in material science and engineering have paved the way for improved design and functionality of absorbable heart stents in the US. The innovation within the US Absorbable Heart Stent Market Industry is driven by Research and Development (R&D) efforts from major medical device companies like Abbott Laboratories and Boston Scientific, who collectively hold a large market share and are responsible for a multitude of patents in stent technology.
The emergence of new biodegradable materials promises better biocompatibility and reduced risk of inflammation, which supports patient recovery significantly. As the FDA continues to highlight innovations through its regulatory pathways, a 12% increase in patent filings related to absorbable stents over the last three years suggests a robust inclination towards investment and innovation, fueling market growth.
The demographic trend in the United States indicates a rapidly increasing geriatric population, which is particularly susceptible to cardiovascular diseases. By 2030, it's estimated that 20% of the US population will be 65 years or older, based on the U.S. Census Bureau projections.
This demographic shift boosts the US Absorbable Heart Stent Market Industry demand, as older adults often require more complex cardiovascular treatments. The improved accessibility to absorbable stents in hospitals and healthcare facilities, coupled with positive clinical outcomes highlighting reduced complications, promotes their adoption among healthcare providers caring for older populations.
Organizations such as the National Institute on Aging continuously focus on advancing geriatric care strategies, which will contribute to the growth of the absorbable heart stent market to accommodate this patient base.
There is a growing trend among both healthcare professionals and patients in the United States towards minimally invasive procedures due to their efficiency and reduced recovery time. The US Absorbable Heart Stent Market Industry benefits uniquely from this trend, as absorbable stents significantly improve procedural outcomes with a less invasive approach compared to traditional stents.
According to the American College of Cardiology, minimally invasive cardiac procedures have seen an uptick in adoption rate of over 15% in recent years, with rising patient preference for techniques that minimize scarring and hospital stays. This healthcare paradigm shift, supported by various leading cardiology associations advocating for less invasive solutions, creates a conducive environment for the growth of absorbable heart stents in the US market.
The US Absorbable Heart Stent Market has witnessed considerable growth, particularly in the Material segment, focusing on advancements in materials such as Metal and Polymer. These materials play a crucial role in the development and efficacy of absorbable heart stents, which serve the essential purpose of providing support to arteries while gradually dissolving after fulfilling their function.
On the other hand, Polymer-based stents are gaining traction due to their tailored bio-absorbable properties, allowing for a more controlled degradation pattern which is significant in minimizing long-term complications and improving patient outcomes. The growing prevalence of cardiovascular diseases in the US drives the demand for innovative heart stent solutions, subsequently enhancing the importance of different materials used in their manufacturing.
Additionally, advances in material science have enabled the development of composite materials that combine the best attributes of both Metal and Polymer, potentially paving the way for hybrid designs that further push the boundaries of stent technology. Market trends indicate a growing preference for these high-performance materials, as research institutes and hospitals advocate for stents that provide better healing rates and reduced re-occlusion rates, which are essential tenets in the treatment of coronary artery disease.
The US Absorbable Heart Stent Market segmentation emphasizes that both Metal and Polymer materials are vital for addressing the needs of an aging population with increasing heart-related issues. Despite their differing properties, both materials contribute significantly to the overall effectiveness and safety of absorbable heart stents.
For instance, Metal stents might be favored for situations requiring immediate structural support, while Polymer counterparts can be essential in cases where gradual absorption at a controlled rate is critical for patient recovery. Furthermore, government initiatives and healthcare reforms in the US strongly favor the adoption of innovative medical technologies, which further validates the growth trajectory of the US Absorbable Heart Stent Market.
These initiatives exemplify overarching trends prioritizing patient safety and improved health outcomes, setting the stage for further advancements in patient-specific stent design based on Material selections. Challenges such as ensuring compatibility with body tissues and achieving optimal absorption timelines remain, but they also present opportunities for continuous innovation within the industry. Overall, the Material segment is a cornerstone for the ongoing evolution of the US Absorbable Heart Stent Market, reflecting both the complexities of cardiovascular health and the potential for medical innovation to enhance patient care.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
The Application segment of the US Absorbable Heart Stent Market plays a crucial role in addressing various cardiovascular conditions, notably Coronary Artery Disease and Peripheral Artery Disease. Coronary Artery Disease, caused by the buildup of plaque in the coronary arteries, is a leading cause of heart attacks in the United States.
As healthcare professionals seek to enhance patient outcomes, the use of these stents is gaining traction. On the other hand, Peripheral Artery Disease is characterized by narrowed arteries reducing blood flow to limbs, impacting mobility and quality of life for many patients.
The growing prevalence of lifestyle-related conditions, such as obesity and diabetes, has led to an increased focus on developing effective treatments, with absorbable stents emerging as a significant option. Collectively, these applications represent key avenues for growth within the US Absorbable Heart Stent Market, driven by evolving patient needs and advancements in medical technology. The emphasis on minimally invasive procedures and patient-centered care continues to foster momentum for these innovative devices in the cardiovascular landscape.
The US Absorbable Heart Stent Market demonstrates substantial segmentation in the End-Use category, which comprises various healthcare facilities critical for managing cardiovascular diseases. Hospitals take precedence in this segment due to their advanced infrastructure and patient care capabilities, often being the primary endpoint for procedures involving absorbable stents.
Additionally, Research Institutes and Organizations contribute through extensive research and development, enhancing the efficacy and safety of these stents. The growing frequency of coronary artery diseases in the US fuels demand across these diverse facilities, leading to increased investments and opportunities for market growth. Overall, each segment within End-Use provides unique contributions to refining patient outcomes in the US Absorbable Heart Stent Market while highlighting the interconnectedness of healthcare services in addressing cardiovascular health.
The competitive landscape of the US Absorbable Heart Stent Market reveals a dynamic and rapidly evolving environment characterized by significant innovation and strategic partnerships among leading players. The market has attracted attention due to its potential for transformative treatment solutions in cardiac care, particularly for patients with coronary artery disease.
Major companies in this sector are focusing on the development of advanced technologies that enhance stent performance, promote faster healing, and minimize complications associated with traditional metal stents. Competitive strategies often include a combination of research and development initiatives, regulatory approvals, and targeted marketing efforts aimed at healthcare providers and institutions.
This competitive insight indicates a robust market where companies are continuously striving to improve patient outcomes while navigating the regulatory landscape and addressing the growing demand for minimally invasive procedures.
Janssen Pharmaceuticals has carved out a significant presence in the US Absorbable Heart Stent Market by leveraging its extensive research capabilities and commitment to innovative solutions in cardiovascular therapies. The company is recognized for its strength in developing advanced medical technologies aimed at optimizing patient safety and treatment efficacy.
Janssen's strategic approach often encompasses collaborations with healthcare professionals and stakeholders, allowing for valuable insights into patient needs and clinical outcomes. This engagement has fostered strong relationships that enhance the company’s reputation within the cardiac care community. As a part of a larger pharmaceutical organization, Janssen benefits from substantial resources that facilitate the introduction of pioneering products in the marketplace, enabling it to maintain a competitive edge in the absorptive stent sector.
Edwards Lifesciences enjoys a prominent position in the US Absorbable Heart Stent Market, characterized by its innovative solutions and high-quality products in heart valve therapies and vascular interventions. The company has established a solid reputation for pioneering technologies that integrate both absorbable and conventional stent designs, contributing to enhanced patient care in cardiovascular treatments.
Edwards Lifesciences' strengths lie in its comprehensive product pipeline that addresses diverse cardiovascular conditions, coupled with a robust market presence bolstered by strategic mergers and acquisitions aimed at expanding its technological capabilities. The company actively invests in research and development, ensuring that its stent offerings are aligned with the latest developments in medical science. Through these efforts, Edwards Lifesciences continues to solidify its leadership role within the US Absorbable Heart Stent Market, demonstrating adaptability and innovation to meet evolving patient and healthcare provider demands.
The US Absorbable Heart Stent Market has seen significant developments, particularly with companies like Janssen Pharmaceuticals, Edwards Lifesciences, and Abbott Laboratories leading in innovation. In June 2023, Edwards Lifesciences announced advancements in their absorbable stent technologies, which aim to enhance patient outcomes and reduce complications.
Additionally, in August 2023, Medtronic launched a new clinical trial for its absorbable stent product line, intending to gather data that could pave the way for regulatory approvals and market expansion. Notably, in terms of mergers and acquisitions, in July 2023, Boston Scientific acquired a smaller firm specializing in biocompatible materials for their stent products, thereby boosting their manufacturing capabilities and strengthening their portfolio.
Overall, growth in valuations for companies like Gore Medical and Stryker Corporation has been driven by increased investment in Research and Development, reflecting a broader trend towards minimally invasive solutions in cardiac care. Major happenings over the last couple of years include FDA approvals for several innovative stent designs, increasing the interest of hospital networks in adopting next-generation absorbable technologies, further solidifying the market’s trajectory in the US.
| Report Attribute/Metric Source: | Details |
| MARKET SIZE 2018 | 23.81(USD Million) |
| MARKET SIZE 2024 | 27.5(USD Million) |
| MARKET SIZE 2035 | 169.0(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 17.947% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| MARKET FORECAST PERIOD | 2025 - 2035 |
| HISTORICAL DATA | 2019 - 2024 |
| MARKET FORECAST UNITS | USD Million |
| KEY COMPANIES PROFILED | Janssen Pharmaceuticals, Edwards Lifesciences, Gore Medical, Philips Healthcare, Terumo Corporation, Cook Medical, Biotronik, MicroPort Scientific, Abbott Laboratories, Cardinal Health, Boston Scientific, Essen BioScience, Medtronic, Stryker Corporation, C.R. Bard |
| SEGMENTS COVERED | Material, Application, End-Use |
| KEY MARKET OPPORTUNITIES | Growing aging population, Increasing cardiovascular diseases, Advancements in stent technology, Rising demand for minimally invasive procedures, Expanding reimbursement policies |
| KEY MARKET DYNAMICS | technological advancements, regulatory approvals, increasing cardiovascular diseases, rising demand for minimally invasive procedures, competitive pricing strategies |
| COUNTRIES COVERED | US |
Frequently Asked Questions (FAQ) :
The US Absorbable Heart Stent Market is expected to be valued at 0.13 billion USD in 2024.
By 2034, the market is anticipated to be valued at 0.18 billion USD.
The expected CAGR for the market from 2025 to 2034 is 2.28 percent.
Key players include NuVasive, Volcano Corporation, Cardinal Health, and Abbott Laboratories, among others.
The market is segmented into Paclitaxel-Eluting Stents, Sirolimus-Eluting Stents, Everolimus-Eluting Stents, and Zotarolimus-Eluting Stents.
In 2024, Paclitaxel-Eluting Stents will be valued at 0.05 billion USD.
By 2034, the market value for Sirolimus-Eluting Stents is expected to be 0.04 billion USD.
The market for Everolimus-Eluting Stents is estimated to be 0.04 billion USD in 2024.
The market value for Zotarolimus-Eluting Stents is expected to reach 0.02 billion USD by 2034.
Key growth drivers include advancements in medical technology and increasing demand for minimally invasive procedures.
By 2035, the US Absorbable Heart Stent Market is projected to reach a value of 169.0 million USD.
The expected CAGR for the US Absorbable Heart Stent Market from 2025 to 2035 is 17.947%.
The polymer material segment is expected to dominate the market, valued at 16.5 million USD in 2024.
The market value of the metal segment is projected to reach 68.0 million USD by 2035.
Major players in the market include Janssen Pharmaceuticals, Edwards Lifesciences, and Boston Scientific among others.
The growing demand for minimally invasive procedures presents significant growth opportunities in the market.
Changes in healthcare regulations could pose challenges or create opportunities for market expansion and innovation.
The demand for advanced cardiac stenting procedures is driving growth in the market.
Innovation in material technology and competitive pricing strategies are key factors influencing market competition.
Leading companies partner with us for data-driven Insights.
Kindly complete the form below to receive a free sample of this Report
Analyst Explore the profile of garvit vyas, one of our esteemed authors at market research future, and access their expert research contributions in the field of market research and industry analysis
Get in Touch
© 2025 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
